Standard
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. / Høgdall, Estrid; Fung, Eric T; Christensen, Ib Jarle; Yip, Christine; Nedergaard, Lotte; Engelholm, Svend Aage; Risum, Signe; Petri, Anette Lykke; Lundvall, Lene; Lomas, Lee; Høgdall, Claus.
I:
Proteomics - Clinical Applications, Bind 4, Nr. 12, 01.12.2010, s. 940-52.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Høgdall, E, Fung, ET, Christensen, IJ, Yip, C, Nedergaard, L, Engelholm, SA, Risum, S, Petri, AL, Lundvall, L, Lomas, L
& Høgdall, C 2010, '
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients',
Proteomics - Clinical Applications, bind 4, nr. 12, s. 940-52.
https://doi.org/10.1002/prca.200900171
APA
Høgdall, E., Fung, E. T., Christensen, I. J., Yip, C., Nedergaard, L., Engelholm, S. A., Risum, S., Petri, A. L., Lundvall, L., Lomas, L.
, & Høgdall, C. (2010).
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.
Proteomics - Clinical Applications,
4(12), 940-52.
https://doi.org/10.1002/prca.200900171
Vancouver
Høgdall E, Fung ET, Christensen IJ, Yip C, Nedergaard L, Engelholm SA o.a.
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.
Proteomics - Clinical Applications. 2010 dec. 1;4(12):940-52.
https://doi.org/10.1002/prca.200900171
Author
Høgdall, Estrid ; Fung, Eric T ; Christensen, Ib Jarle ; Yip, Christine ; Nedergaard, Lotte ; Engelholm, Svend Aage ; Risum, Signe ; Petri, Anette Lykke ; Lundvall, Lene ; Lomas, Lee ; Høgdall, Claus. / Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. I: Proteomics - Clinical Applications. 2010 ; Bind 4, Nr. 12. s. 940-52.
Bibtex
@article{d75a09f8e2814cc78e24861123778b79,
title = "Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients",
abstract = "To determine if the level of apolipoprotein A1, hepcidin, transferrin, inter-a trypsin IV internal fragment, transthyretin (TT), connective-tissue activating protein 3 (CTAP3), serum amyloid A1, {\ss}-2 microglobulin (B2M) might have impact on overall and progression-free survival for ovarian cancer (OC) patients.",
author = "Estrid H{\o}gdall and Fung, {Eric T} and Christensen, {Ib Jarle} and Christine Yip and Lotte Nedergaard and Engelholm, {Svend Aage} and Signe Risum and Petri, {Anette Lykke} and Lene Lundvall and Lee Lomas and Claus H{\o}gdall",
note = "Copyright {\textcopyright} 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.",
year = "2010",
month = dec,
day = "1",
doi = "http://dx.doi.org/10.1002/prca.200900171",
language = "English",
volume = "4",
pages = "940--52",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley - V C H Verlag GmbH & Co. KGaA",
number = "12",
}
RIS
TY - JOUR
T1 - Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
AU - Høgdall, Estrid
AU - Fung, Eric T
AU - Christensen, Ib Jarle
AU - Yip, Christine
AU - Nedergaard, Lotte
AU - Engelholm, Svend Aage
AU - Risum, Signe
AU - Petri, Anette Lykke
AU - Lundvall, Lene
AU - Lomas, Lee
AU - Høgdall, Claus
N1 - Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2010/12/1
Y1 - 2010/12/1
N2 - To determine if the level of apolipoprotein A1, hepcidin, transferrin, inter-a trypsin IV internal fragment, transthyretin (TT), connective-tissue activating protein 3 (CTAP3), serum amyloid A1, ß-2 microglobulin (B2M) might have impact on overall and progression-free survival for ovarian cancer (OC) patients.
AB - To determine if the level of apolipoprotein A1, hepcidin, transferrin, inter-a trypsin IV internal fragment, transthyretin (TT), connective-tissue activating protein 3 (CTAP3), serum amyloid A1, ß-2 microglobulin (B2M) might have impact on overall and progression-free survival for ovarian cancer (OC) patients.
U2 - http://dx.doi.org/10.1002/prca.200900171
DO - http://dx.doi.org/10.1002/prca.200900171
M3 - Journal article
VL - 4
SP - 940
EP - 952
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
SN - 1862-8346
IS - 12
ER -
